Stability Indicating HPLC Method for In-vitro Determination of Pantoprazole Sodium and its Degradation Products in Simulated Gastric and Intestinal Fluids

被引:0
|
作者
Gupta, Avani [1 ,2 ]
Akhtar, Juber [2 ]
Rastogi, Kailash Chandra [1 ]
Badruddeen [2 ]
Khan, Mohammad Irfan [2 ]
Ahmad, Mohammad [2 ]
机构
[1] Hygia Inst Pharmaceut Educ & Res, Dept Pharmaceut, Lucknow 226020, Uttar Pradesh, India
[2] Integral Univ, Fac Pharm, Dept Pharmaceut, Lucknow 226026, Uttar Pradesh, India
关键词
Stability Indicating assay; RP HPLC; LOQ; LOD; pantoprazole; PPIs; acid degradation; PROTON-PUMP INHIBITORS; ASSAY-METHODS; HUMAN PLASMA; LANSOPRAZOLE; RABEPRAZOLE; OMEPRAZOLE; QUANTIFICATION; DRUGS; VALIDATION; ITOPRIDE;
D O I
10.2174/0115734129254806231127110951
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: A high-performance liquid chromatography (HPLC) method was developed for the determination of Pantoprazole Sodium (PPZ) in the presence of its degradation products. The degradation of PPZ was studied in simulated intestinal fluid (SIF) and simulated gastric fluids (SGF) in various temperature conditions. Aim: This study aimed to establish a simple, sensitive, and rapid RP HPLC method for in -vitro determination of Pantoprazole Sodium and its degradation products in simulated gastric and intestinal fluids. Objective: Pantoprazole is acid labile drug. In order to determine pantoprazole in various oral dosage forms, the stability -indicating assay of PPZ was performed in phosphate buffer (pH 6.8) representing simulated intestinal fluid (SIF) and in 0.1 molars (M) Hydrochloric acid (HCl) as simulated gastric fluid (SGF) at two different temperature conditions, i.e., 25 degrees C and 0 degrees C, respectively. Methods: Pantoprazole sodium was obtained from the Akums laboratory in Haridwar. The analysis was performed by high-performance liquid chromatography (HPLC), Shimadzu, equipped with two LC -10 AD VP solvent -delivery modules, a SPD-10A UV- -visible detector, and a manual injector valve with 20 mu L sample loop. Phenomenex ODS analytical column (150 mm x 4.6 mm i.d., 5 mu m particles) was done under reversed -phase partition chromatographic conditions. The mobile phase was phosphate buffer and acetonitrile (ACN) of pH 7.4, respectively, optimized in a 70:30 (v/v) ratio followed by filtration through a 0.45 mu m membrane filter and degassed by ultrasonicator before use. The mobile phase was delivered at the flow rate of 2 mL/min. The various parameters, such as linearity, accuracy and precision of the analytical method, were studied. Results: The standard curve of PPZ was linear (R2>0.99) over the concentration range of 5-30 mu g/mL, and the relative standard deviation (RSD) values for intra-day and inter -day variations were in the range of 1.0-1.8%. The range of RSD was within +/- 2. Conclusion: The stability of PPZ in aqueous solution was pH dependent. The rate of degradation increases with decreasing pH. The pH stability of pantoprazole was studied at the above -mentioned temperature conditions. The PPZ peaks were analyzed by comparing them with fresh samples and were stable in SIF solution after 24 hours elapsed time at pH 6.8. The obtained degraded peaks in SGF (pH 1) were successfully separated from the PPZ.
引用
收藏
页码:767 / 775
页数:9
相关论文
共 50 条
  • [1] Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine
    Asafu-Adjaye, Ebenezer B.
    Faustino, Patrick J.
    Tawakkul, Mobin A.
    Anderson, Lawrence W.
    Yu, Lawrence X.
    Kwon, Hyojong
    Volpe, Donna A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (05) : 1854 - 1859
  • [2] Validated Stability-Indicating HPLC Method for the Determination of Mesna in Presence of Its Degradation Products
    Rizk, Mohamed
    Taha, Elham A.
    Mowaka, Shereen
    Abdallah, Youmna M.
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2015, 53 (05) : 742 - 748
  • [3] Stability-Indicating HPLC Method for Determination of Ibuprofen and Famotidine Degradation Products
    Atilgan, Nurdan
    Tabansiz, Gizem
    Turkes, Ezgi
    Sarracoglu, Nagehan
    Doganay, Asuman Aybey
    Pinarbasli, Onur
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2024, 62 (08) : 751 - 760
  • [4] A stability indicating HPLC method for determination of mebeverine in the presence of its degradation products and kinetic study of its degradation in oxidative condition
    Souri, E.
    Aghdami, A. Negahban
    Adib, N.
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2014, 9 (03) : 199 - 206
  • [5] Stability-Indicating HPLC and HPTLC Methods for Determination of Agomelatine and its Degradation Products
    Abdelrahman, Maha M.
    Naguib, Ibrahim A.
    El Ghobashy, Mohamed R.
    Ali, Nesma A.
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2018, 56 (04) : 317 - 326
  • [6] A Stability-Indicating RP-HPLC-UV method for determination of fidaxomicin and its hydrolytic degradation products
    K. Vinod Kumar
    Hemraj Sharma
    Ramalingam Peraman
    SarvaSree Pudipatla
    Journal of the Iranian Chemical Society, 2022, 19 : 785 - 792
  • [7] Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products
    Aprile, Silvio
    Canavesi, Rossana
    Bianchi, Michele
    Grosa, Giorgio
    Del Grosso, Erika
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 132 : 66 - 71
  • [8] Stability indicating RP-HPLC method for simultaneous determination of pantoprazole sodium and itopride hydrochloride in bulk and capsule
    Gupta, Krishna R.
    Chawla, Rajesh B.
    Wadodkar, Sudhir G.
    ORBITAL-THE ELECTRONIC JOURNAL OF CHEMISTRY, 2010, 2 (03): : 209 - 224
  • [9] A Stability-Indicating RP-HPLC-UV method for determination of fidaxomicin and its hydrolytic degradation products
    Kumar, K. Vinod
    Sharma, Hemraj
    Peraman, Ramalingam
    Pudipatla, SarvaSree
    JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2022, 19 (03) : 785 - 792
  • [10] Development and validation of a stability-indicating HPLC-UV method for the determination of alizapride and its degradation products
    Tamaro, Ilaria
    Aprile, Silvio
    Giovenzana, Giovanni B.
    Grosa, Giorgio
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 51 (05) : 1024 - 1031